PBLS Financials

Income Statement
MetricQ2 2026
Revenue
148.0K
Cost of Revenue
0
Gross Profit
148.0K
Operating Expenses
51.0M
R&D
39.4M
SG&A
11.7M
Operating Income
-50886000
EBITDA
-50886000
Net Income
-46907000
EPS (Basic)
$-2.32
EPS (Diluted)
$-2.32
Shares (Diluted)
28.9M
MarketsMoversWatchlist
Parabilis Medicines (PBLS) — Financials